Transplantation osteoporosis

Transplantation Reviews

Volumn 15, Issue 1, 2001, Pages 11-32

  Shane, Elizabeth ^a,b   Epstein, Solomon ^a,b  

^a Surgeons of Columbia University ^*  (United States)

^b Roche Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001781877     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1053/trre.2001/19535     Document Type: Article

References (18)

1. Rodino MA, Shane E: Osteoporosis after organ transplantation. Am J Med 1998, 104:459
2. Epstein S, Shane E: Transplantation osteoporosis, in Marcus R, Feldman D, Kelsey J (eds): Osteoporosis. San Diego, Academic Press, in press, 2001
3. Park KM, Hay JE, Lee SG, et al: Bone loss after orthotopic liver transplantation: FK506 versus cyclosporine. Transplant Proc 1996, 28:1738
4. Stempfle HU, Werner C, Echtler S, et al: Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. Transplant Proc 1998, 30: 1132
5. Mundy GR: Bone remodeling, in Favus MJ, (ed): Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Philadelphia, Lippincott Williams and Wilkins, 1999, p 30
6. Epstein S: Post-transplantation bone disease: The role of immunosuppressive agents on the skeleton. J Bone Miner Res 1996, 11:1
7. Lane NE, Lukert B: The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am 1998, 27:465
8. Manolagas SC, Weinstein RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14:1061
9. Weinstein RS, Jilka RL, Parfilt AM, et al: Inhibition of osteoblastogenesis and promotion of apoptosis of osleoblasts and osteocytes by glucocorlicoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274
10. Dempster DW: Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 1989, 4:137
11. Shane E, Addesso-Dodd V, Mancini D: Bone loss persists after cardiac transplantation despite the use of lower glucocorlicoid doses [abstract]. J Bone Miner Res 2000, 15:5542
12. Van Staa TP, Lcufkens HG, Abenhaim L, et al: Use of oral corticosleroids and risk of fractures. J Bone Miner Res 2000, 15:993
13. Kahan BD: Cyclosporine. N Engl J Mcd 1989, 321:1725
14. Suthanthiran M, Strom TB: Renal transplantation. N Engl J Med 1994, 331:365
15. Movsowitz C, Epstein S, Fallon M, et al: Cyclosporin A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 1988, 123:2571
16. Movsowitz C, Epstein S, Ismail F, et al: Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption. J Bone Miner Res 1989, 4:393
17. Buchinsky F, Ma Y, Mann G, et al: T lymphocytes play a critical role in the development of cyclosporine induced osteopenia. Endocrinology 1996, 137:2278
18. Rucinski B, Liu CC, Epstein S: Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osleopenia in the rat. Metabolism 1994, 43:1114